Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GVB-2001 in Primary Open Angle Glaucoma
NCT06921317Phase 2Recruiting
- Sponsor
- IVIEW Therapeutics Inc.
- Start
- Nov 2025
- Primary completion
- Dec 2027
- Modality
- Gene Editing, Gene Silencing, Viral Vectors
- Countries
- 1
01
Overview
A Phase 2 trial of GVB-2001 in primary open-angle glaucoma (POAG), sponsored by IVIEW Therapeutics Inc.. Started Nov 2025; status: recruiting.
02
Drugs
GVB-2001
03
Conditions
primary open-angle glaucoma (POAG)
Beyond the preview
Go deeper on NCT06921317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06921317.